Personalized mRNA-based cancer vaccine shows promise
Drugmakers Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large late-stage trial involving high-risk melanoma patients. ––– Subscribe to ABC News on YouTube: https://abcnews.visitlink.me/59aJ1G…